HALO
Halozyme Therapeutics Inc
Price:  
36.00 
USD
Volume:  
1,210,754.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Relative Valuation

39.7%
Upside

As of 2024-02-21, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 50.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.00 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 39.7%.

The range of the Relative Valuation is 43.02 - 56.87 USD.

Range Selected
Trailing P/E multiples 22.4x - 29.0x 25.8x
Forward P/E multiples 21.5x - 24.4x 21.9x
Fair Price 43.02 - 56.87 50.30
Upside 19.5% - 58.0% 39.7%
36.00 USD
Stock Price
50.30 USD
Fair Price

HALO Relative Valuation - Historical P/E Data

Date P/E
2024-02-21 19.92
2024-02-20 18.73
2024-02-16 18.78
2024-02-15 18.68
2024-02-14 18.24
2024-02-13 18.02
2024-02-12 18.57
2024-02-09 18.46
2024-02-08 18.33
2024-02-07 18.37
2024-02-06 18.22
2024-02-05 17.52
2024-02-02 17.52
2024-02-01 17.82
2024-01-31 17.61
2024-01-30 17.57
2024-01-29 17.90
2024-01-26 17.80
2024-01-25 17.95
2024-01-24 18.24
2024-01-23 18.08
2024-01-22 17.69
2024-01-19 17.77
2024-01-18 18.17
2024-01-17 18.75
2024-01-16 18.92
2024-01-12 17.91
2024-01-11 17.71
2024-01-10 18.02
2024-01-09 18.20
2024-01-08 18.48
2024-01-05 18.27
2024-01-04 19.02
2024-01-03 18.62
2024-01-02 19.45
2023-12-29 19.23
2023-12-28 19.33
2023-12-27 19.20
2023-12-26 19.44
2023-12-22 19.33
2023-12-21 19.19
2023-12-20 18.93
2023-12-19 20.49
2023-12-18 20.19
2023-12-15 20.30
2023-12-14 20.53
2023-12-13 21.90
2023-12-12 20.94
2023-12-11 21.07
2023-12-08 20.79